Work

Study of anti-PD-1 antibody pembrolizumab and pegylated-interferon alfa-2b (Peg-IFN) for advanced melanoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e20018

Authors: Hassane M. Zarour, Hussein Tawbi, Ahmad A. Tarhini, Hong Wang, Cindy Sander, Amy Rose, Julien J. Fourcade, Joe-Marc Chauvin, Zhaojun Sun, Ornella Pagliano, John M. Kirkwood

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2348125801

Cites:

Cited by: 8

Related to: 10